Therefore, the 4 conventional serum tumor markers, CYFRA21-1, CEA, SCCA, and NSE, were suggested to be effective supplements for the 8 lung cancer autoantibodies obtained in this study in distinguishing early-stage NSCLC. The gene discussed is ENO2; the disease is non-small cell lung carcinoma.